Sino Biopharmaceutical Overview

  • Status
  • Public
  • Employees
  • 24,443
Employees
  • Stock Symbol
  • 01177
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $0.72
  • (As of Friday Closing)

Sino Biopharmaceutical General Information

Description

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 24 billion revenue in 2019. Its four most important therapeutic areas are hepatitis, oncology, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • 1 Harbour Road
  • Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai
  • Hong Kong
  • Hong Kong
+852 2802 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sino Biopharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.72 $0.73 $0.68 - $1.25 $13.6B 18.8B 38.6M $0.08

Sino Biopharmaceutical Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 19,040,274 19,033,803 17,963,734 7,957,779
Revenue 3,823,959 3,422,863 3,507,278 3,157,627
EBITDA 2,104,039 983,880 1,028,772 1,904,038
Net Income 1,509,904 401,106 399,665 1,367,493
Total Assets 8,693,868 7,226,124 5,361,621 4,220,287
Total Debt 2,111,828 2,174,984 1,231,406 507,980
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sino Biopharmaceutical Executive Team (2)

Name Title Board Seat Contact Info
Li Yi Executive Director & Chief Executive Officer
Mao Li Chief Medical Officer
To view Sino Biopharmaceutical’s complete executive team members history, request access »

Sino Biopharmaceutical Board Members (6)

Name Representing Role Since
00000 00 Sino Biopharmaceutical Board Member 000 0000
0000000 000 Self Chairman & Board Member 000 0000
000 0000 00.0 Sino Biopharmaceutical Founder & Chairman 000 0000
000 0000000 Sino Biopharmaceutical Chairman 000 0000
00000000 00 00.0 Sino Biopharmaceutical Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Sino Biopharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sino Biopharmaceutical Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 18-Nov-2021 00000 0000 0000 Biotechnology 000 00
00000000 31-Mar-2021 0000000000 00000 Therapeutic Devices 000 00000
0000000 07-Dec-2020 0000 00000 Pharmaceuticals
0000000 09-Nov-2020 000 00000 Pharmaceuticals
Akeso Biopharma 02-Nov-2019 Later Stage VC 00000 Drug Discovery
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Sino Biopharmaceutical Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 07-Dec-2020 0000 00000 Completed
  • 0000 0000000000000
00000 000000000 02-Nov-2019 00000 00000 00 00000 Completed
  • 11 buyers
LifeBond 05-Aug-2015 Later Stage VC 0000 Completed
  • 12 buyers
To view Sino Biopharmaceutical’s complete exits history, request access »